Structural Development Study of a Novel Pharmacological Chaperone for Folding-Defective Rhodopsin Mutants Responsible for Retinitis Pigmentosa

Yakugaku Zasshi - Japan
doi 10.1248/yakushi.131.325
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

A Rhodopsin Gene Mutation Responsible for Autosomal Dominant Retinitis Pigmentosa Results in a Protein That Is Defective in Localization to the Photoreceptor Outer Segment

Journal of Neuroscience
Neuroscience
1994English

Rhodopsin Mutations in Chinese Patients With Retinitis Pigmentosa

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2001English

Molecular Study of the Rhodopsin Gene in Retinitis Pigmentosa Patients in the Basque Country.

Journal of Medical Genetics
Genetics
1998English

Flavonoid Allosteric Modulation of Mutated Visual Rhodopsin Associated With Retinitis Pigmentosa

Scientific Reports
Multidisciplinary
2017English

A Case of Monocular Retinitis Pigmentosa

Hans Journal of Ophthalmology
2017English

A Genetic Analysis of Retinitis Pigmentosa.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1983English

3. Development of Pharmacological Chaperone Therapy for Neuronopathic Gaucher Disease

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2017English

AAV Delivery of Wild-Type Rhodopsin Preserves Retinal Function in a Mouse Model of Autosomal Dominant Retinitis Pigmentosa

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2011English

Risk Factors for Posterior Subcapsular Cataract in Retinitis Pigmentosa

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy